Brayan Styven Merchan Rojas1; Jose Luis De-la-hoz1; Gustavo Facchini2; Gustavo Henrique da Silva2; Ana Lúcia Tabarini Alves Pinheiro3; Samara Eberlin2
1. Megalabs SAS, Research and Development, Bogotá, Cundinamarca, Colombia
2. Kosmoscience Group, Skin Vitro, Pre-Clinical Safety and Efficacy Laboratory, Valinhos (SP), Brazil
3. Kosmoscience Group, Clinical Research, Valinhos (SP), Brazil
Samara Eberlin Email: samara@kosmoscience.com / Alternative email: samara.eberlin@gmail.com